Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Steuber

Showing results (91-100 of 209) with videos related to

Pageof 21
Sort By:
BJU International|October 17, 2013
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?Sami-Ramzi Leyh-Bannurah, Jens Hansen, Hendrik Isbarn, et al.
Clinical Genitourinary Cancer|October 26, 2019
Impact of Adherence to Multidisciplinary Recommendations for Adjuvant Treatment in Radical Prostatectomy Patients With High Risk of RecurrenceSophie Knipper, Maryam Sadat-Khonsari, Katharina Boehm, et al.
European Urology|January 28, 2006
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathologyFelix K-H Chun, Thomas Steuber, Andreas Erbersdobler, et al.
World Journal of Urology|November 2, 2024
Influence of metastatic sites and burden on oncological outcomes in patients progressing to metastatic castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Clara Humke, et al.
The Prostate|May 30, 2024
Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real-world setting of metastatic hormone-sensitive prostate cancer patientsMike Wenzel, Benedikt Hoeh, Fabienne Hurst, et al.
European Urology Focus|December 6, 2024
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: An Updated Network Meta-analysis Including ARANOTE DataBenedikt Hoeh, Mike Wenzel, Zhe Tian, et al.
European Urology|August 15, 2006
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomyFelix K-H Chun, Alberto Briganti, Claudio Jeldres, et al.
European Urology Focus|June 11, 2019
Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trialPhilipp C Mandel, Hartwig Huland, Anne Tiebel, et al.
World Journal of Urology|September 8, 2019
Comparison of intra- and postoperative analgesia and pain perception in robot-assisted vs. open radical prostatectomySophie Knipper, Moritz Hagedorn, Maryam Sadat-Khonsari, et al.
European Urology Open Science|July 22, 2024
Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer PatientsMike Wenzel, Carolin Siech, Benedikt Hoeh, et al.
Pageof 21

Showing results (91-100 of 209) with videos related to

Sort By:
Pageof 21
BJU International|October 17, 2013
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?Sami-Ramzi Leyh-Bannurah, Jens Hansen, Hendrik Isbarn, et al.
Clinical Genitourinary Cancer|October 26, 2019
Impact of Adherence to Multidisciplinary Recommendations for Adjuvant Treatment in Radical Prostatectomy Patients With High Risk of RecurrenceSophie Knipper, Maryam Sadat-Khonsari, Katharina Boehm, et al.
European Urology|January 28, 2006
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathologyFelix K-H Chun, Thomas Steuber, Andreas Erbersdobler, et al.
World Journal of Urology|November 2, 2024
Influence of metastatic sites and burden on oncological outcomes in patients progressing to metastatic castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Clara Humke, et al.
The Prostate|May 30, 2024
Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real-world setting of metastatic hormone-sensitive prostate cancer patientsMike Wenzel, Benedikt Hoeh, Fabienne Hurst, et al.
European Urology Focus|December 6, 2024
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: An Updated Network Meta-analysis Including ARANOTE DataBenedikt Hoeh, Mike Wenzel, Zhe Tian, et al.
European Urology|August 15, 2006
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomyFelix K-H Chun, Alberto Briganti, Claudio Jeldres, et al.
European Urology Focus|June 11, 2019
Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trialPhilipp C Mandel, Hartwig Huland, Anne Tiebel, et al.
World Journal of Urology|September 8, 2019
Comparison of intra- and postoperative analgesia and pain perception in robot-assisted vs. open radical prostatectomySophie Knipper, Moritz Hagedorn, Maryam Sadat-Khonsari, et al.
European Urology Open Science|July 22, 2024
Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer PatientsMike Wenzel, Carolin Siech, Benedikt Hoeh, et al.
Pageof 21